Alle Nachrichten zur COVALENT Aktie | COVALENT News

DAX	6.050	-3,4%	Dow	12.119	-2,2%	Euro	1,2432	0,6%
ESt50	2.069	-2,4%	Nas	2.748	-2,8%	Öl	98,82	-2,8%
TDax	730,9	-2,7%	Nikkei	8.440	-1,2%	Gold	1.626	4,2%

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Depot
Times + Sales	Chart-Analyse	Analysen	Dividende/HV	Profil	Optionsscheine	Watchlist
Börsenplätze	Chartvergleich	Kursziele		Insidertrades	Knock-outs	myHome
Orderbuch	Realtime Stuttgart	RSS Feed		im Forum	Fonds	Senden
	Realtime Push	myNews neu		IR-Daten	Anleihen	handeln

Sprache:
Alle
DE
EN

Sortieren:
Datum
meistgelesen

29.03.12	SAS-Covalent acquisition to take effect today (EN, Chinapost)
14.08.08	Encorium Reports 2008 Second Quarter Financial Results (Businesswire)
14.08.08	Encorium Group Schedules Second Quarter Financial Results and Conference Call (Businesswire)
13.08.08	Encorium Group Signs $3.5 Million of New Contracts for Vaccines Clinical Trials (Businesswire)
22.07.08	Encorium Group Signs Additional New Contracts Valued at $5.0 Million (Businesswire)
17.07.08	Encorium Group Announces $5.1 Million New Business Contract For A Multinational Cardiovascular Trial Of An Innovative Anti-thrombotic Agent (Businesswire)
11.06.08	Encorium Group, Inc. Announces Signing of Letter of Intent to Acquire Prologue Research International, Inc. (Businesswire)
11.06.08	Encorium Group, Inc. Announces Signing of Letter of Intent to Combine with Linkcon; Expected Expansion Will Create Global CRO (Businesswire)
22.05.08	Encorium Group, Inc. Announces $3.2 Million of New Business Contracts for Europe and North America (Businesswire)
15.05.08	Encorium Reports 2008 First Quarter Financial Results (Businesswire)
13.05.08	Encorium Group Appoints Philip L. Calamia Interim Chief Financial Officer (Businesswire)
12.05.08	Encorium Group Schedules First Quarter Financial Results and Conference Call (Businesswire)
18.04.08	Encorium Group, Inc. Announces the Resignation of Lawrence R. Hoffman as Chief Financial Officer; Company to Immediately Begin Search for Successor (Businesswire)
07.04.08	Encorium Group, Inc. Announces Additional $2.2 Million of New Business Contracts With Multiple European and U.S. Biopharmaceutical Companies (Businesswire)
31.03.08	Encorium Group, Inc. Announces $1.6 Million Contract for a Phase 2 Trial of an Innovative Immunotherapeutic Vaccine for the Treatment of Hypertension (Businesswire)
25.03.08	Encorium Reports 2007 Fourth Quarter and Full Year Financial Results (Businesswire)
24.03.08	Encorium Group, Inc. Announces $2.5 Million of Awarded New Business Contracts With Multiple European and U.S. Biopharmaceutical Companies (Businesswire)
20.03.08	Encorium Group Schedules Fourth Quarter Financial Results and Conference Call (Businesswire)
21.02.08	Encorium Group, Inc. Announces Realignment of Its Senior Management Team to Meet Its Global Growth Objectives (Businesswire)
18.01.08	Encorium Group, Inc. Announces $3.4 Million of Awarded New Business Contracts (Businesswire)
10.01.08	Encorium Group, Inc. Announces Signing of $1.7 Million in Contracts with Leading International Biotechnology Company for Clinical Trials in Oncology and Rheumatology (Businesswire)
07.01.08	Encorium Group, Inc. Announces the Signing of a $2.0 Million Contract for Data Management Services for a Global Pharmaceutical Company (Businesswire)
12.11.07	Encorium Reports 2007 Third Quarter Financial Results (Businesswire)
12.11.07	Encorium Group Appoints Biopharmaceutical Industry Veteran Linda Nardone Ph.D. as Chief Operating Officer (Businesswire)
05.11.07	Encorium Group Schedules Third Quarter Financial Results and Conference Call (Businesswire)
25.10.07	Encorium Group, Inc. Announces $4 Million of Awarded New Business Contracts (Businesswire)
28.08.07	Encorium Group Forms Joint Venture in Biostatistics, Data Management, and Consulting Services (Businesswire)
13.08.07	Encorium Reports 2007 Second Quarter Financial Results (Businesswire)
06.08.07	Encorium Group Schedules Second Quarter Financial Results and Conference Call (Businesswire)
26.07.07	Encorium Group, Inc. Schedules Date for Annual Meeting of Stockholders (Businesswire)
17.07.07	Encorium Group, Inc. Announces $4.0 Million of Additional New Business Contracts (Businesswire)
12.07.07	Encorium Group, Inc. Announces $1.7 Million Contract With Japanese Biotechnology Company For Phase 2 Clinical Trial For Major Depressive Disorder (Businesswire)
10.07.07	Encorium Group, Inc. Announces $3.0 Million in New Contracts for Clinical Trials in Women's Health (Businesswire)
21.06.07	Encorium Group, Inc. Announces $3.8 Million Contract For Phase 2 Clinical Trial in Herpes Zoster (Shingles) (Businesswire)
19.06.07	Oramed Pharmaceuticals Signs Agreement With Encorium Group To Commence Investigational New Drug Application (Businesswire)
01.11.06	Encorium Group Completes Combination with Remedium (Businesswire)

Finanzen.net

Covalent Aktie [WKN: 898635 / ISIN: US2228151021]

Nachrichten zu Covalent

Newssuche

Meistgelesene Covalent News 1M

Covalent Peer Group News